These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11535559)
1. Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: recovering the missing link in left ventricular remodeling. Mann DL; Taegtmeyer H Circulation; 2001 Sep; 104(10):1089-91. PubMed ID: 11535559 [No Abstract] [Full Text] [Related]
2. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571 [TBL] [Abstract][Full Text] [Related]
3. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398 [TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair. Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169 [TBL] [Abstract][Full Text] [Related]
6. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051 [TBL] [Abstract][Full Text] [Related]
7. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Tozzi R; Palladini G; Fallarini S; Nano R; Gatti C; Presotto C; Schiavone A; Micheletti R; Ferrari P; Fogari R; Perlini S Am J Hypertens; 2007 Jun; 20(6):663-9. PubMed ID: 17531925 [TBL] [Abstract][Full Text] [Related]
9. Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure. Sakamuri SS; Takawale A; Basu R; Fedak PW; Freed D; Sergi C; Oudit GY; Kassiri Z Transl Res; 2016 Jun; 172():30-44. PubMed ID: 26963743 [TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling and failure From molecules to man (Part II). Fedak PW; Verma S; Weisel RD; Li RK Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796 [TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. Krebber MM; van Dijk CGM; Vernooij RWM; Brandt MM; Emter CA; Rau CD; Fledderus JO; Duncker DJ; Verhaar MC; Cheng C; Joles JA Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937927 [TBL] [Abstract][Full Text] [Related]
12. Molecular changes after left ventricular assist device support for heart failure. Birks EJ Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719 [TBL] [Abstract][Full Text] [Related]
13. [Left ventricular assist device - unexpected benefits for the failing heart]. Pasierski T; Buksińska-Lisik M Kardiol Pol; 2008 Jun; 66(6):678-83. PubMed ID: 18626838 [No Abstract] [Full Text] [Related]
14. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling. Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988 [TBL] [Abstract][Full Text] [Related]
17. Myocardial proteases and matrix remodeling in inflammatory heart disease. Rutschow S; Li J; Schultheiss HP; Pauschinger M Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902 [TBL] [Abstract][Full Text] [Related]
18. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471 [TBL] [Abstract][Full Text] [Related]
19. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. Margulies KB J Card Fail; 2002 Dec; 8(6 Suppl):S500-5. PubMed ID: 12555165 [TBL] [Abstract][Full Text] [Related]
20. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Schram K; Sweeney G Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]